The definitive guide to the multidisciplinary specialty of pharmaceutical medicine, encompassing scientific, medical and related activities in the discovery, development, evaluation, registration and monitoring of medicines, the execution of clinical trials, and the regulatory and ethical requirements pertaining to drug development. The journal publishes peer-reviewed original research and review articles covering all aspects of pharmaceutical medicine, from the processes involved in the identification of new active substances, through their development and licensing as medicinal products, to the monitoring of their use in clinical practice.
Pharmaceutical Medicine offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers in understanding important medical advances.The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.
There are no publication charges for standard publishing in Pharmaceutical Medicine; the journal offers the option of Open Access publication via Springer Open Choice (article processing charge €2,040 / US$2,690). Please click on the link below under ‘Publishing model’ for further information about this service.
- Susan Pochon
- Publishing model
- Hybrid. Open Access options available
- 33 days
- Submission to first decision
- 94 days
- Submission to acceptance
- 23,885 (2018)